Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
X-PLORE phase 2 trial of CNTO 1959 in moderate to severe plaque psoriasis
2011-001066-17Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of guselkumab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Started Aug 2011; status: completed.
02
Drugs
guselkumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2011-001066-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001066-17.